Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_assertion type Assertion NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_head.
- NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_assertion description "[We investigated if the MET-activating point mutation Y1253D influences clinical outcomes in patients with advanced squamous cell carcinoma of the head and neck (HNSCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_provenance.
- NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_assertion evidence source_evidence_literature NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_provenance.
- NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_assertion SIO_000772 19639388 NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_provenance.
- NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_assertion wasDerivedFrom befree-20140225 NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_provenance.
- NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_assertion wasGeneratedBy ECO_0000203 NP347820.RAV0I5QhetSMbLXQgkcPFRkNV9J8zFGO7aOtTz-Gyf-58130_provenance.